Status
Conditions
Treatments
About
With the advent of the aging society, dementia becomes the focus of common people. As for the neurodegeneration dementia, no disease modifying treatments have been discovered. Idiopathic normal pressure hydrocephalus (iNPH) is considered as one of reversible dementia, which can be hint by the surgery. In addition, dementia of iNPH is the typical subcortical dementia. Therefore exploring the pathogenic mechanism is conducive to the early diagnosis and treatment. This research is to monitor the changing of iNPHGS, cognitive function, walking ability as well as brain construction imaging and neural network before and after ventriculo-peritoneal shunting in order to demonstrate the pathogenesis of triads. In the process, the supplementary test, for instance, CSF tap test, will be validated the predictive value.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
ncluded will be subjects with a probable diagnosis of NPH. The diagnosis will be based primarily on presence of gait impairment plus at least one other impairment in urinary symptoms, cognition impairment or both.
Are 50 years old or older
Patients who understand the study protocol
Patients who meet the criteria for NPH
Exclusion criteria
60 participants in 2 patient groups
Loading...
Central trial contact
Liling Dong, MD; Caiyan Liu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal